FDA Drug recall D-0111-2018
Methylphenidate Hydrochloride Extended-release Tablets, USP 54 mg, 100-count bottles, Rx Only, Trigen Laboratories, LLC. Bridgewater, NJ 08…
- FDA Drug
- Class III
- terminated
- Published 2017-12-27
On 2017-12-27 the FDA classified a Class III recall of Methylphenidate Hydrochloride Extended-release Tablets, USP 54 mg, 100-count bottles, Rx Only, Trigen Laboratories, LLC. Bridgewater, NJ 08… by Osmotica Pharmaceutical, citing subpotent Drug.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0111-2018 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2017-12-18 |
| Published | 2017-12-27 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Osmotica Pharmaceutical |
| Distribution | US |
Product
Methylphenidate Hydrochloride Extended-release Tablets, USP 54 mg, 100-count bottles, Rx Only, Trigen Laboratories, LLC. Bridgewater, NJ 08807, NDC 13811-709-10
Reason
Subpotent Drug
Identifiers
| ndc | 13811-709-10 |
|---|---|
| ndc | 13811-706-10 |
| ndc | 13811-707-10 |
| ndc | 13811-708-10 |
| ndc | 13811-710-10 |
| ndc | 13811-710-30 |
| code_info | Lot #: 170029A, Exp. 02/2019; 170030A, Exp. 02/2019 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0111-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.